Use of genome-wide RNAi screening to identify modes of action of bioactive compounds
Project/Area Number |
15K12759
|
Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
Allocation Type | Multi-year Fund |
Research Field |
Chemical biology
|
Research Institution | Institute of Physical and Chemical Research |
Principal Investigator |
Matsumoto Ken 国立研究開発法人理化学研究所, 吉田化学遺伝学研究室, 専任研究員 (60222311)
|
Project Period (FY) |
2015-04-01 – 2017-03-31
|
Project Status |
Completed (Fiscal Year 2016)
|
Budget Amount *help |
¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2015: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
Keywords | 化合物 / RNAi / スクリーニング / 標的同定 / shRNAスクリーニング / 化合物標的 |
Outline of Final Research Achievements |
Genome-wide RNA interference (RNAi) with pooled and barcoded short-hairpin RNA (shRNA) libraries provides a powerful tool for identifying cellular components that are relevant to the modes/mechanisms of action of bioactive compounds. We used multiplex barcode sequencing technology which enables parallel analysis of multiple samples. An shRNA library screen with this system revealed that downregulation of ATP1A1, a catalytic subunit of Na+/K+ ATPase, conferred significant sensitivity to aurilide B, a natural marine product that induces mitochondria-mediated apoptosis. Combined treatment with ouabain which inhibits Na+/K+ ATPase by targeting catalytic subunits potentiated sensitivity to aurilide B.
|
Report
(3 results)
Research Products
(8 results)
-
[Journal Article] A quantitative shRNA screen identifies ATP1A1 as a gene that regulates cytotoxicity by aurilide B.2017
Author(s)
Takase, S., Kurokawa, R., Arai, D., Kanto, K. K., Okino, T., Nakao, Y., Kushiro, T., Yoshida, M., and Matsumoto, K.
-
Journal Title
Scientific Reports
Volume: 印刷中
Related Report
Peer Reviewed / Open Access / Int'l Joint Research / Acknowledgement Compliant
-
[Journal Article] YBX1 gene silencing inhibits migratory and invasive potential via CORO1C in breast cancer in vitro2017
Author(s)
Lim, J. P., Shyamasundar, S., Gunaratne, J., Scully, O. J., Matsumoto, K., and Bay, B.-H.
-
Journal Title
BMC Cancer
Volume: 17
Issue: 1
Pages: 201-201
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
[Journal Article] PRAS40 deregulates apoptosis in Ewing sarcoma family tumors by enhancing the insulin receptor/Akt and mTOR signaling pathways.2016
Author(s)
Lv, D., Liu, J., Guo, L., Wu, D., Matsumoto, K., and Huang, L.
-
Journal Title
American Journal of Cancer Research
Volume: 6
Pages: 486-497
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-
-
-
-